Fonte: Gynecologic Oncology. Unidade: FMRP
Assuntos: NEOPLASIAS, DOENÇAS DOS GENITAIS FEMININOS
ABNT
MARANA, Heitor Ricardo Cosiski e SILVA, João Santana da e ANDRADE, Jurandyr Moreira de. NK cell activity in the presence of IL-12 is a prognostic assay to neoadjuvant chemotherapy in cervical cancer. Gynecologic Oncology, v. 78, p. 318-3123, 2000Tradução . . Acesso em: 30 set. 2024.APA
Marana, H. R. C., Silva, J. S. da, & Andrade, J. M. de. (2000). NK cell activity in the presence of IL-12 is a prognostic assay to neoadjuvant chemotherapy in cervical cancer. Gynecologic Oncology, 78, 318-3123.NLM
Marana HRC, Silva JS da, Andrade JM de. NK cell activity in the presence of IL-12 is a prognostic assay to neoadjuvant chemotherapy in cervical cancer. Gynecologic Oncology. 2000 ; 78 318-3123.[citado 2024 set. 30 ]Vancouver
Marana HRC, Silva JS da, Andrade JM de. NK cell activity in the presence of IL-12 is a prognostic assay to neoadjuvant chemotherapy in cervical cancer. Gynecologic Oncology. 2000 ; 78 318-3123.[citado 2024 set. 30 ]